{"schema":"sb.node.v1","id":"sb:e/1fc27bf6479dd65aefea8221","kind":"entity","label":{"text":"drug administration","locale":"en"},"identity":{"anchor":"label:en:drug administration","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-08T23:32:17.032179+00:00","snapshot":"deploy 30eccbd0a92992f24ee73467899162618bbca4e7"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":672,"separatePublishers":94,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-06","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.449: about 55% of mentions carry no typed assertion"]}},"dimensions":{"domains":["pharma-regulatory","biotech_pharma"],"activeDays":95,"assertions":{"regulatory-approval":210,"utterance":20,"launch-release":18,"military-action":16,"legal-ruling":10,"meeting-visit":8}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/1fbd1ca5cf914f93fdf8aaaa","kind":"observation","label":"Oklahoma Farm Report · 2026-09-04 · Produce Safety Leader for U.S. Food & Drug Administration to Discuss Opportunities with State Agriculture Officials","url":"https://www.oklahomafarmreport.com/2026/09/03/produce-safety-leader-for-u-s-food-drug-administration-to-discuss-opportunities-with-state-agriculture-officials/?utm_source=rss&utm_medium=rss&utm_campaign=produce-safety-leader-for-u-s-food-drug-administration-to-discuss-opportunities-with-state-agriculture-officials"},{"id":"sb:o/8f5ebc8fa84b2099f2f9181e","kind":"observation","label":"FDA Drug News · 2026-07-13 · Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs","url":"http://www.fda.gov/regulatory-information/search-fda-guidance-documents/formal-meetings-between-food-and-drug-administration-and-sponsors-or-requestors-over-counter"},{"id":"sb:o/717d737a22f661dbf7a93f38","kind":"observation","label":"FDA Drug News · 2026-10-07 · [APPROVAL] The Platinum Healthcare LLC - 735147 - 10/01/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/platinum-healthcare-llc-735147-10012026"},{"id":"sb:o/cc83974bd16d85c672228c5c","kind":"observation","label":"FDA · 2026-10-07 · Walmart, Inc. - 736557 - 10/01/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/walmart-inc-736557-10012026"},{"id":"sb:o/63ece5aa3b26a87720e265f7","kind":"observation","label":"Clinical Trials Arena · 2026-10-07 · ViiV Healthcare’s Cabenuva beats daily oral ART in Phase IIIb trial","url":"https://www.clinicaltrialsarena.com/news/viiv-healthcares-cabenuva-beats-daily-oral-art-in-phase-iiib-trial/"},{"id":"sb:o/84f15c26c77f52522c6815e7","kind":"observation","label":"FDA · 2026-10-07 · TCI Co., Ltd BioCosme PABP BRANCH - 736888 - 09/02/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tci-co-ltd-biocosme-pabp-branch-736888-09022026"},{"id":"sb:o/019eccada7401dda1ae1cc49","kind":"observation","label":"STAT News · 2026-10-07 · STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more","url":"https://www.statnews.com/pharmalot/2026/10/06/us-funded-psychedelic-trials-astrazeneca-research-center/?utm_campaign=rss"},{"id":"sb:o/2c54babaf084a2cb5f90a45c","kind":"observation","label":"STAT News · 2026-10-07 · STAT+: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few","url":"https://www.statnews.com/2026/10/07/muscular-dystrophy-exon-skipping-drugs-novartis-dyne/?utm_campaign=rss"},{"id":"sb:o/03dfc2138ae238d5cf5450d5","kind":"observation","label":"STAT News · 2026-10-07 · STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down","url":"https://www.statnews.com/2026/10/07/caribou-biosciences-shutting-down-lymphoma-car-t-therapy/?utm_campaign=rss"},{"id":"sb:o/4a4639ceb9cb08abd864bdff","kind":"observation","label":"BBC News · 2026-10-07 · Rainmakers: The drones used to seed clouds","url":"https://www.bbc.co.uk/news/articles/c64g71j4lgyjo?at_medium=RSS&at_campaign=rss"}],"cursor":"c1.eyJpZCI6InNiOmUvMWZjMjdiZjY0NzlkZDY1YWVmZWE4MjIxIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA4VDIzOjMyOjE3LjAzMjE3OSswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":{"state":"cannot-measure","reason":"claims: this subject's maintained record could not be read (the maintained record \"drug-administration\" could not measure its claims: this subject was retired from the publication registry on 2026-09-30 (no longer clears the admission conditions — re-checked 2026-09-30 (no receipt in the corpus-evidence shard for this label)); the record is kept as a dated tombstone and is no longer maintained). The items listed come from the passes that could be read"},"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with fda (668 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a6cee2b412dbbbbfb39e47cd"},{"kind":"relation","label":"co-mentioned with u.s. food (261 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a4270c844bf88061915d7b09"},{"kind":"relation","label":"co-mentioned with united states (123 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/6c523d8b99e13b3e9ee9aabd"},{"kind":"relation","label":"co-mentioned with public health (110 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/1a8828f39bd502858909fa9a"},{"kind":"relation","label":"co-mentioned with us food (102 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/9da1ccc5edc5d0659dc43284"},{"kind":"relation","label":"co-mentioned with trump (94 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4eb89cc3085ee2b45d89386f"},{"kind":"relation","label":"co-mentioned with united states congress (81 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ba3c38afc1577a848e559957"},{"kind":"relation","label":"co-mentioned with clinical trial (80 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/32c24038316988b932839076"},{"kind":"relation","label":"co-mentioned with human services (69 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/31289fdce8950568d9fd4086"},{"kind":"relation","label":"co-mentioned with drug evaluation (68 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/c254ba73c2b7806edd1e2c44"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/1fc27bf6479dd65aefea8221","mcp":"traverse {\"id\":\"sb:e/1fc27bf6479dd65aefea8221\"}","page":"/entity/drug-administration/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1fc27bf6479dd65aefea8221\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1fc27bf6479dd65aefea8221\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1fc27bf6479dd65aefea8221\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/1fc27bf6479dd65aefea8221\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}